ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Selexis, Inotrem Partner to Advance Inotrem’s Inflammatory Disease Program
January 19, 2022Inotrem will leverage Selexis’ SUREtechnology Platform, a suite of cell line development technologies. -
Inotrem gets clearance to launch phase 2 trial of Nangibotide in Covid-19 patients
July 29, 2020Inotrem S.A., a biotechnology company specialized in the development of immunotherapies targeting the TREM-1 pathway, announced that it has obtained authorization to launch its phase IIa clinical trial in COVID-19 patients in France, Belgium and the USA. -
US FDA fast tracks Inotrem’s nangibotide for septic shock
September 04, 2019The US Food and Drug Administration (FDA) has awarded fast track designation to French biotechnology firm Inotrem’s nangibotide programme, which is being developed to treat septic shock.
Pharma Sources Insight January 2025
